Healthcare

Clinical Trials Support Services Market Size to Rake US$ 45.2 Bn through 2030

The global Clinical Trials Support Services market size is expected to be worth around US$ 45.2 billion by 2030, according to a new report by Vision Research Reports.

Clinical Trials Support Services Market (By Phase: Phase I, Phase II, Phase III, Phase IV; By Service: Clinical trial site management, Patient recruitment management, Data management, Administrative staff, IRB, Others; By Sponsor: Pharmaceutical & biopharmaceutical companies, Medical device companies,  Others) – Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021 – 2030

Get Sample Copy of This Report@ https://www.visionresearchreports.com/report/sample/38321

Report Highlights

 The phase III segment dominated the global market and accounted for the largest revenue share of 63.6% in 2020. The fact that phase III studies are the most expensive and include a large number of participants drives the segment growth. As a result, demand for the phase III component rises.

The phase I segment is anticipated to register the fastest CAGR during the forecast period. Despite the tendency of outsourcing, developing nations only host a small fraction of phase I studies. As a result of the aforementioned factors, as well as rising healthcare spending, an increasing number of Investigational New Drug (IND) applications filed, and the trend of outsourcing, the drug development process is projected to drive the market.

The clinical trial site management segment accounted for the maximum revenue share of 53.2% in 2020 and is likely to remain dominant during the forecast years. The segment is also projected to witness the fastest CAGR of 10.7% from 2021 to 2028. Clinical trial site management services for managing offshore operations have seen tremendous expansion as a result of the trend of clinical trial outsourcing.

Proper site management by the sponsor and/or CRO is crucial for trial execution and trial success. A sufficient degree of site administration and monitoring enables facilities to efficiently recruit, treat, and retain subjects while maintaining regulatory compliance, protocol adherence, subject rights protection, subject safety, and overall management of screened and recruited subjects.

The pharmaceutical & biopharmaceutical companies sponsor segment dominated the market with the largest revenue share of over 79% in 2020. The segment is also anticipated to witness the fastest CAGR from 2021 to 2030. This is largely attributed to the increasing R&D investments and introduction of new drugs, which have increased in the past two decades.

The medical device companies segment is anticipated to show lucrative growth over the forecast period. In the clinical research industry, medical device manufacturers are minor customers, and clinical research sites generally focus on the more profitable sectors of biotechnology, pharmaceuticals, and fundamental research. However, as the FDA places an increasing focus on excellent clinical procedures, device makers will find themselves interacting with this complicated business on a far more regular basis.

North America region dominated the global market in 2020 with the largest share of 60.7% as most of the pharmaceutical businesses located in the U.S. perform a majority of their business in this region. Asia Pacific is anticipated to be the fastest-growing regional market over the forecast period. Factors driving the APAC market include a developing patient population, simplicity of administrative compliance, minimal expense of conducting studies, and the presence of a couple of top clinical organizations acting at sites.

Key Players

  • Charles River Laboratories
  • IQVIA
  • Pharmaceutical Product Development LLC
  • WuXi AppTec
  • Parexel International
  • Icon PLC
  • Laboratory Corp. of America Holdings
  • Novotech

Market Segmentation

  • Phase Outlook
    • Phase I
    • Phase II
    • Phase III
    • Phase IV
  • Service Outlook
    • Clinical trial site management
    • Patient recruitment management
    • Data management
    • Administrative staff
    • IRB
    • Others
  • Sponsor Outlook
    • Pharmaceutical & biopharmaceutical companies
    • Medical device companies
    • Others
  • Regional Outlook
    • North America
      • U.S.
      • Canada
    • Europe
      • U.K.
      • Germany
      • France
      • Italy
      • Spain
    • Asia Pacific
      • Japan
      • China
      • India
      • Thailand
      • South Korea
    • Latin America
      • Brazil
      • Mexico
      • Argentina
      • Colombia
    • Middle East and Africa (MEA)
      • South Africa
      • Saudi Arabia
      • UAE

Buy This Report, click here@ https://www.visionresearchreports.com/report/cart/38321

Reasons to Purchase this Report:

– Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
– Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
– Market value USD Million and volume Units Million data for each segment and sub-segment
– Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
– Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players

Research Methodology:

In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.

This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.

Table of Contents

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Clinical Trials Support Services Market, By Phase

7.1.  Clinical Trials Support Services Market, by Phase, 2021-2030

7.1.1.    Phase I

7.1.1.1.        Market Revenue and Forecast (2016-2030)

7.1.2.    Phase II

7.1.2.1.        Market Revenue and Forecast (2016-2030)

7.1.3.    Phase III

7.1.3.1.        Market Revenue and Forecast (2016-2030)

7.1.4.    Phase IV

7.1.4.1.        Market Revenue and Forecast (2016-2030)

Chapter 8.  Global Clinical Trials Support Services Market, By Service

8.1.  Clinical Trials Support Services Market, by Service, 2021-2030

8.1.1.    Clinical trial site management

8.1.1.1.        Market Revenue and Forecast (2016-2030)

8.1.2.    Patient recruitment management

8.1.2.1.        Market Revenue and Forecast (2016-2030)

8.1.3.    Data management

8.1.3.1.        Market Revenue and Forecast (2016-2030)

8.1.4.    Administrative staff

8.1.4.1.        Market Revenue and Forecast (2016-2030)

8.1.5.    IRB

8.1.5.1.        Market Revenue and Forecast (2016-2030)

Chapter 9.  Global Clinical Trials Support Services Market, By Sponsor

9.1.  Clinical Trials Support Services Market, by Sponsor, 2021-2030

9.1.1.    Pharmaceutical & biopharmaceutical companies

9.1.1.1.        Market Revenue and Forecast (2016-2030)

9.1.2.    Medical device companies

9.1.2.1.        Market Revenue and Forecast (2016-2030)

9.1.3.    Others

9.1.3.1.        Market Revenue and Forecast (2016-2030)

Chapter 10.      Global Clinical Trials Support Services Market, Regional Estimates and Trend Forecast

10.1.        North America

10.1.1.  Market Revenue and Forecast, by Phase (2016-2030)

10.1.2.  Market Revenue and Forecast, by Service (2016-2030)

10.1.3.  Market Revenue and Forecast, by Sponsor (2016-2030)

10.1.4.  U.S.

10.1.4.1.      Market Revenue and Forecast, by Phase (2016-2030)

10.1.4.2.      Market Revenue and Forecast, by Service (2016-2030)

10.1.4.3.      Market Revenue and Forecast, by Sponsor (2016-2030)

10.1.5.  Rest of North America

10.1.5.1.      Market Revenue and Forecast, by Phase (2016-2030)

10.1.5.2.      Market Revenue and Forecast, by Service (2016-2030)

10.1.5.3.      Market Revenue and Forecast, by Sponsor (2016-2030)

10.2.        Europe

10.2.1.  Market Revenue and Forecast, by Phase (2016-2030)

10.2.2.  Market Revenue and Forecast, by Service (2016-2030)

10.2.3.  Market Revenue and Forecast, by Sponsor (2016-2030)

10.2.4.  UK

10.2.4.1.      Market Revenue and Forecast, by Phase (2016-2030)

10.2.4.2.      Market Revenue and Forecast, by Service (2016-2030)

10.2.4.3.      Market Revenue and Forecast, by Sponsor (2016-2030)

10.2.5.  Germany

10.2.5.1.      Market Revenue and Forecast, by Phase (2016-2030)

10.2.5.2.      Market Revenue and Forecast, by Service (2016-2030)

10.2.5.3.      Market Revenue and Forecast, by Sponsor (2016-2030)

10.2.6.  France

10.2.6.1.      Market Revenue and Forecast, by Phase (2016-2030)

10.2.6.2.      Market Revenue and Forecast, by Service (2016-2030)

10.2.6.3.      Market Revenue and Forecast, by Sponsor (2016-2030)

10.2.7.  Rest of Europe

10.2.7.1.      Market Revenue and Forecast, by Phase (2016-2030)

10.2.7.2.      Market Revenue and Forecast, by Service (2016-2030)

10.2.7.3.      Market Revenue and Forecast, by Sponsor (2016-2030)

10.3.        APAC

10.3.1.  Market Revenue and Forecast, by Phase (2016-2030)

10.3.2.  Market Revenue and Forecast, by Service (2016-2030)

10.3.3.  Market Revenue and Forecast, by Sponsor (2016-2030)

10.3.4.  India

10.3.4.1.      Market Revenue and Forecast, by Phase (2016-2030)

10.3.4.2.      Market Revenue and Forecast, by Service (2016-2030)

10.3.4.3.      Market Revenue and Forecast, by Sponsor (2016-2030)

10.3.5.  China

10.3.5.1.      Market Revenue and Forecast, by Phase (2016-2030)

10.3.5.2.      Market Revenue and Forecast, by Service (2016-2030)

10.3.5.3.      Market Revenue and Forecast, by Sponsor (2016-2030)

10.3.6.  Japan

10.3.6.1.      Market Revenue and Forecast, by Phase (2016-2030)

10.3.6.2.      Market Revenue and Forecast, by Service (2016-2030)

10.3.6.3.      Market Revenue and Forecast, by Sponsor (2016-2030)

10.3.7.  Rest of APAC

10.3.7.1.      Market Revenue and Forecast, by Phase (2016-2030)

10.3.7.2.      Market Revenue and Forecast, by Service (2016-2030)

10.3.7.3.      Market Revenue and Forecast, by Sponsor (2016-2030)

10.4.        MEA

10.4.1.  Market Revenue and Forecast, by Phase (2016-2030)

10.4.2.  Market Revenue and Forecast, by Service (2016-2030)

10.4.3.  Market Revenue and Forecast, by Sponsor (2016-2030)

10.4.4.  GCC

10.4.4.1.      Market Revenue and Forecast, by Phase (2016-2030)

10.4.4.2.      Market Revenue and Forecast, by Service (2016-2030)

10.4.4.3.      Market Revenue and Forecast, by Sponsor (2016-2030)

10.4.5.  North Africa

10.4.5.1.      Market Revenue and Forecast, by Phase (2016-2030)

10.4.5.2.      Market Revenue and Forecast, by Service (2016-2030)

10.4.5.3.      Market Revenue and Forecast, by Sponsor (2016-2030)

10.4.6.  South Africa

10.4.6.1.      Market Revenue and Forecast, by Phase (2016-2030)

10.4.6.2.      Market Revenue and Forecast, by Service (2016-2030)

10.4.6.3.      Market Revenue and Forecast, by Sponsor (2016-2030)

10.4.7.  Rest of MEA

10.4.7.1.      Market Revenue and Forecast, by Phase (2016-2030)

10.4.7.2.      Market Revenue and Forecast, by Service (2016-2030)

10.4.7.3.      Market Revenue and Forecast, by Sponsor (2016-2030)

10.5.        Latin America

10.5.1.  Market Revenue and Forecast, by Phase (2016-2030)

10.5.2.  Market Revenue and Forecast, by Service (2016-2030)

10.5.3.  Market Revenue and Forecast, by Sponsor (2016-2030)

10.5.4.  Brazil

10.5.4.1.      Market Revenue and Forecast, by Phase (2016-2030)

10.5.4.2.      Market Revenue and Forecast, by Service (2016-2030)

10.5.4.3.      Market Revenue and Forecast, by Sponsor (2016-2030)

10.5.5.  Rest of LATAM

10.5.5.1.      Market Revenue and Forecast, by Phase (2016-2030)

10.5.5.2.      Market Revenue and Forecast, by Service (2016-2030)

10.5.5.3.      Market Revenue and Forecast, by Sponsor (2016-2030)

Chapter 11.  Company Profiles

11.1.              Charles River Laboratories

11.1.1.  Company Overview

11.1.2.  Product Offerings

11.1.3.  Financial Performance

11.1.4.  Recent Initiatives

11.2.              IQVIA

11.2.1.  Company Overview

11.2.2.  Product Offerings

11.2.3.  Financial Performance

11.2.4.  Recent Initiatives

11.3.              Pharmaceutical Product Development LLC

11.3.1.  Company Overview

11.3.2.  Product Offerings

11.3.3.  Financial Performance

11.3.4.  Recent Initiatives

11.4.              WuXi AppTec

11.4.1.  Company Overview

11.4.2.  Product Offerings

11.4.3.  Financial Performance

11.4.4.  Recent Initiatives

11.5.              Parexel International

11.5.1.  Company Overview

11.5.2.  Product Offerings

11.5.3.  Financial Performance

11.5.4.  Recent Initiatives

11.6.              Icon PLC

11.6.1.  Company Overview

11.6.2.  Product Offerings

11.6.3.  Financial Performance

11.6.4.  Recent Initiatives

11.7.              Laboratory Corp. of America Holdings

11.7.1.  Company Overview

11.7.2.  Product Offerings

11.7.3.  Financial Performance

11.7.4.  Recent Initiatives

11.8.              Novotech

11.8.1.  Company Overview

11.8.2.  Product Offerings

11.8.3.  Financial Performance

11.8.4.  Recent Initiatives

Chapter 12.  Research Methodology

12.1.              Primary Research

12.2.              Secondary Research

12.3.              Assumptions

Chapter 13.  Appendix

13.1.              About Us

Glossary of Terms

Buy This Report, click here@ https://www.visionresearchreports.com/report/cart/38321

About Us: Our team of skilled and experienced analysts specializes in troubleshooting problems faced by our clients. For comprehensive summary of our services and market research requirements for Global industry.

Contact Us:

call: +1 9197 992 333

Vision Research Report

Any Assistance, Email – sales@visionresearchreports.com

Show More

Precedence Research

Precedence Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings.

Related Articles

Back to top button